Top vendors for Imaging AI, compared

Six AI-powered imaging companies spanning ultrasound, digital pathology, brain MRI, MR spectroscopy, enterprise radiology, and retinal imaging — what each one does and who it's built for.

TL;DR

"Imaging AI" here covers very different clinical ground, so this isn't a horse race — it's six vendors solving six distinct problems. Butterfly Network, Inc. brings AI to handheld point-of-care ultrasound via its iQ3 probe, including a recently FDA-cleared gestational age estimation tool. PathAI targets anatomic pathology labs and biopharma with its cloud-native AISight® platform for AI-assisted histopathology. Darmiyan, Inc. focuses narrowly on early Alzheimer's and dementia detection from standard brain MRI, with FDA De Novo approval for BrainSee. BrainSpec, Inc adds a complementary neurology angle through cloud-based MR Spectroscopy analysis. Canon Medical Informatics, Inc. offers the broadest enterprise footprint with its Vitrea® Advanced Visualization platform across cardiology, thoracic, and general radiology. And identifeye HEALTH Inc. is building an AI-assisted retinal imaging platform for point-of-care systemic and ophthalmologic screening.

Because these vendors address entirely different imaging disciplines, your procurement decision is mostly about which clinical problem you're solving — not which vendor wins a feature comparison.

At a glance

Vendor	Imaging Type	Clinical Specialty	Deployment	Primary Setting
Butterfly Network, Inc.	Ultrasound	POCUS, OB, emergency	Handheld probe + cloud app	Bedside / point of care
PathAI	Digital pathology slides	Histopathology, oncology	Cloud-native (AISight®)	Pathology lab, biopharma
Darmiyan, Inc.	Brain MRI	Neurodegeneration (Alzheimer's)	Cloud-based software	Neurology / memory clinic
BrainSpec, Inc	MR Spectroscopy	Neurology, neuro-oncology	Cloud (BrainSpec Core™)	Radiology, clinical research
Canon Medical Informatics, Inc.	CT, cardiac, thoracic imaging	Cardiology, radiology	Cloud-ready enterprise platform	Hospital / health system
identifeye HEALTH Inc.	Retinal fundus imaging	Ophthalmology, systemic health	Point-of-care device + AI	Primary care, eye clinic

Pricing: None of these vendors publish list prices publicly. Request quotes directly from each.

How they compare

Clinical focus: six genuinely different problems

The clearest dividing line is anatomical. Butterfly Network and identifeye HEALTH are both point-of-care platforms, but they image completely different anatomy — whole-body ultrasound versus the retina. Canon Medical Informatics operates at health-system scale across CT and cardiac CT: its CT VScore+ module automates cardiac calcium scoring, and Open Rib handles chest CT image reformation with PACS integration. PathAI works entirely within the pathology lab on digitized tissue slides. Darmiyan and BrainSpec both target neurology, but through different MRI-based methods. Darmiyan's BrainSee performs voxel-level analysis of standard brain MRI to detect microscopic tissue architecture changes associated with Alzheimer's. BrainSpec Core™ analyzes MR Spectroscopy data, quantifying brain metabolite concentrations at precision levels its technical documentation describes as 10,000 times lower than conventional MRI signal — a meaningful technical distinction for neuro-oncology and metabolic brain disease workups.

If your procurement need spans more than one of these domains, you're almost certainly evaluating vendors from different rows of this table, not choosing between them.

Regulatory maturity and clinical validation

Darmiyan holds the most clearly documented regulatory milestone in this group: FDA De Novo authorization for BrainSee covering early detection and monitoring of neurodegenerative disease. The De Novo pathway matters here — it establishes a new device classification rather than relying on a substantially equivalent predicate, meaning FDA reviewed this as a genuinely novel tool.

Butterfly Network has multiple FDA clearances for AI features on the iQ3. Its gestational age estimation tool — trained on more than 21 million images in collaboration with researchers at the University of North Carolina at Chapel Hill — received 510(k) clearance in early 2026, the first clearance of its kind for a blind-sweep ultrasound AI. Canon Medical Informatics is a mature enterprise software organization with Vitrea as an established radiology platform. PathAI operates in digital pathology workflow software, where FDA's stance on laboratory-side AI tools continues to evolve — verify the regulatory status of specific AISight® algorithms for your intended diagnostic use before procurement. BrainSpec's and identifeye HEALTH's regulatory clearance status are not confirmed in publicly available documentation; identifeye explicitly describes its AI suite as in development.

Deployment model and IT lift

Butterfly Network requires the least IT infrastructure: the iQ3 is a handheld probe that connects to a smartphone or tablet. For a rural clinic or resource-limited setting, that's a concrete operational advantage over enterprise platforms requiring PACS integration and server configuration.

PathAI's AISight® is cloud-native and open-architecture — designed to ingest whole-slide images and connect with existing laboratory information systems. That matters for labs that already own a digital pathology scanner and want an AI layer rather than a wholesale platform swap. Canon's Vitrea sits at the other end of the complexity spectrum, built for enterprise-wide deployment with structured data delivery via its Export+ module. Brain